Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Short Interest Up 600.3% in May

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the recipient of a large increase in short interest in May. As of May 29th, there was short interest totaling 252,647 shares, an increase of 600.3% from the May 14th total of 36,079 shares. Based on an average daily trading volume, of 413,217 shares, the days-to-cover ratio is currently 0.6 days. Currently, 6.2% of the shares of the stock are short sold.

Hedge Funds Weigh In On Defiance Daily Target 2X Long LLY ETF

A hedge fund recently bought a new stake in Defiance Daily Target 2X Long LLY ETF stock. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 5,433 shares of the company’s stock, valued at approximately $138,000. Thurston Springer Miller Herd & Titak Inc. owned 0.34% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent reporting period.

Defiance Daily Target 2X Long LLY ETF Price Performance

LLYX stock traded up $1.06 on Thursday, reaching $26.25. The company had a trading volume of 453,766 shares, compared to its average volume of 482,486. Defiance Daily Target 2X Long LLY ETF has a 1 year low of $9.60 and a 1 year high of $28.44. The company’s fifty day moving average is $19.83 and its 200 day moving average is $21.91.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.